These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 23212430)

  • 1. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    Prozialeck WC; Jivan JK; Andurkar SV
    J Am Osteopath Assoc; 2012 Dec; 112(12):792-9. PubMed ID: 23212430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Pharmacology and Legal Status of Kratom.
    Prozialeck WC
    J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kratom policy: The challenge of balancing therapeutic potential with public safety.
    Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
    Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do you know about Kratom?
    Eladely AA; Shahzad J; Lippmann S
    Postgrad Med; 2020 Aug; 132(6):536-537. PubMed ID: 32315574
    [No Abstract]   [Full Text] [Related]  

  • 8. A Case Report of Kratom Addiction and Withdrawal.
    Galbis-Reig D
    WMJ; 2016 Feb; 115(1):49-52; quiz 53. PubMed ID: 27057581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kratom: Substance of Abuse or Therapeutic Plant?
    Gorelick DA
    Psychiatr Clin North Am; 2022 Sep; 45(3):415-430. PubMed ID: 36055730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.
    Singh D; Narayanan S; Vicknasingam B; Corazza O; Santacroce R; Roman-Urrestarazu A
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28544011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence.
    McWhirter L; Morris S
    Eur Addict Res; 2010; 16(4):229-31. PubMed ID: 20798544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.
    Henningfield JE; Fant RV; Wang DW
    Psychopharmacology (Berl); 2018 Feb; 235(2):573-589. PubMed ID: 29273821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kratom.
    Sanderson M; Rowe A
    CMAJ; 2019 Oct; 191(40):E1105. PubMed ID: 31591097
    [No Abstract]   [Full Text] [Related]  

  • 15. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kratom: a primer for pain physicians.
    Emerick T; Durbhakula S; Eibel MR; Kohan L
    Curr Opin Anaesthesiol; 2024 Oct; 37(5):575-580. PubMed ID: 39011659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do You Get What You Paid For? An Examination of Products Advertised as Kratom.
    Griffin OH; Daniels JA; Gardner EA
    J Psychoactive Drugs; 2016; 48(5):330-335. PubMed ID: 27669103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiology of Kratom and its main alkaloid mitragynine.
    Suhaimi FW; Yusoff NH; Hassan R; Mansor SM; Navaratnam V; Müller CP; Hassan Z
    Brain Res Bull; 2016 Sep; 126(Pt 1):29-40. PubMed ID: 27018165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kratom: A growing substance of abuse in the United States.
    Demick DS; Lee TT; Summers AT; El-Mallakh RS
    Ann Clin Psychiatry; 2020 Nov; 32(4):275-280. PubMed ID: 32722734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial and adverse health effects of kratom (Mitragyna speciosa): A critical review of the literature.
    Heywood J; Smallets S; Paustenbach D
    Food Chem Toxicol; 2024 Oct; 192():114913. PubMed ID: 39134135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.